Partner with us to advance your research through in vivo proof of concept and beyond!

LAB eN² (pronounced Lab ee – en – squared) combines the power of two world class companies, Novo Nordisk and Evotec, into a novel partnership designed to accelerate the translation of innovative academic drug discovery ideas from bench to bedside!

Our model aims to bring life-changing therapies based on your discoveries to people living with cardiometabolic conditions and rare blood disorders in an efficient and expedited manner.